Summary
Cellevate proposes a completely novel type of nanofibrous microcarriers for adherent cell culture in bioreactors based on the proprietary Superior Biologics Manufacturing Platform (SBMP). It is a game-changing deep-tech innovation for the biopharmaceutical industry. SBPM-microcarriers
are highly customizable, faithfully replicate the 3D extracellular environment found in the human body, and provide a 60 times larger area for cell growth compared to competitive solutions. The unique scaffold properties are a result of a patent-pending nanofiber scaffold production
technology (PCT/EP2020/081958) which creates networks of polymer nanofibers that can be handled in a liquid form, unachievable by competing solutions. By offering high yields and ensuring the optimal conditions for human cell growth, SBMP-microcarriers have the potential to transform the
biopharmaceutical market by pushing the limits of today’s biological drugs production to an unachievable level of quality and efficiency.
are highly customizable, faithfully replicate the 3D extracellular environment found in the human body, and provide a 60 times larger area for cell growth compared to competitive solutions. The unique scaffold properties are a result of a patent-pending nanofiber scaffold production
technology (PCT/EP2020/081958) which creates networks of polymer nanofibers that can be handled in a liquid form, unachievable by competing solutions. By offering high yields and ensuring the optimal conditions for human cell growth, SBMP-microcarriers have the potential to transform the
biopharmaceutical market by pushing the limits of today’s biological drugs production to an unachievable level of quality and efficiency.
Unfold all
/
Fold all
More information & hyperlinks
Web resources: | https://cordis.europa.eu/project/id/190187799 |
Start date: | 01-10-2022 |
End date: | 30-09-2024 |
Total budget - Public funding: | 3 551 225,00 Euro - 2 485 857,00 Euro |
Cordis data
Original description
Cellevate proposes a completely novel type of nanofibrous microcarriers for adherent cell culture in bioreactors based on the proprietary Superior Biologics Manufacturing Platform (SBMP). It is a game-changing deep-tech innovation for the biopharmaceutical industry. SBPM-microcarriersare highly customizable, faithfully replicate the 3D extracellular environment found in the human body, and provide a 60 times larger area for cell growth compared to competitive solutions. The unique scaffold properties are a result of a patent-pending nanofiber scaffold production
technology (PCT/EP2020/081958) which creates networks of polymer nanofibers that can be handled in a liquid form, unachievable by competing solutions. By offering high yields and ensuring the optimal conditions for human cell growth, SBMP-microcarriers have the potential to transform the
biopharmaceutical market by pushing the limits of today’s biological drugs production to an unachievable level of quality and efficiency.
Status
SIGNEDCall topic
HORIZON-EIC-2022-ACCELERATOROPEN-01Update Date
09-02-2023
Images
No images available.
Geographical location(s)